IP Library Granted Patent US 10,590,137
Granted Patent B2
US 10,590,137 · App. 16/074,438 · Granted Mar 17, 2020

Mercaptopurine hemihydrate

Inventors: Adam J. Matzger (Ann Arbor, MI); Kortney Kersten (Ann Arbor, MI)
Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
C07D473/38A61P35/02A61P37/00C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,590,137
App. No.
16/074,438
Granted
Mar 17, 2020
Kind
B2
Abstract

Provided herein is a new mercaptopurine form, as a hemihydrate, and methods of making and using the same.

Claims (10)

1. Mercaptopurine hemihydrate.

2. The mercaptopurine hemihydrate of claim 1 having a dehydration temperature of greater than 200° C.

3. The mercaptopurine hemihydrate of claim 2 having a dehydration temperature of 240° C.

4. The mercaptopurine hemihydrate of claim 1 having at least 7 2Θ values selected from the group consisting of 10.59±0.1, 14.14±0.1, 15.86±0.1, 16.25±0.1, 18.83±0.1, 20.80±0.1, 20.42±0.1, 21.35±0.1, 24.93±0.1, 25.75±0.1, 26.02±0.1, 27.97±0.1, and 28.54±0.1°, as measured using CuKα radiation.

5. The mercaptopurine hemihydrate of claim 4 , having 2Θ values 10.59±0.1, 14.14±0.1, 15.86±0.1, 16.25±0.1, 18.83±0.1, 20.80±0.1, 20.42±0.1, 21.35±0.1, 24.93±0.1, 25.75±0.1, 26.02±0.1, 27.97±0.1, and 28.54±0.1°, as measured using CuKα radiation.

6. The mercaptopurine hemihydrate of claim 1 having a crystal structure as represented by the following parameters as measured at 85K: a (Å) 9.361, b (Å) 11.069, c (Å) 13.091, α(°) 90, β(°) 110.3, and γ(°) 90.

7. The mercaptopurine hemihydrate of claim 1 having a Raman spectrum with wavenumber shifts 444±2, 577±2, and 674±2 cm −1 , as measured using a 633 nm laser.

8. A method of making the mercaptopurine hemihydrate of claim 1 , comprising dissolving mercaptopurine monohydrate in methanol to form a methanol solution, contacting the methanol solution with water to form a solution, and crystallizing the mercaptopurine hemihydrate from the solution.

9. The method of claim 8 , wherein the ratio (parts per volume) of methanol to water in the solution is 100:1 to less than 2:1.

10. The method of claim 9 , wherein the ratio is 50:1 to 5:1.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 17, 2021
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 057517/0080 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2018
From: MATZGER, ADAM J.; KERSTEN, KORTNEY
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 046582/0791 →
Continuity (2)
Provisional Application 62290093 · Feb 2, 2016
Related Publication 20190048010A1 · Feb 14, 2019